Share
1,121 Posts.
lightbulb Created with Sketch. 214
clock Created with Sketch. 24/04/24
12:34
Share
Originally posted by Dungiven:
↑
To be fair, he doesn't say that funding options won't be looked at until FDA confirms 2x2 / Phase III, he actually says non-dilutionary funding will "likely coincide" with confirmation - and progress - on 2x2. I'd suggest a large pinch of salt with anything that comes from anyone associated with PAR these days, but that's interesting phrasing to see from someone with intimate knowledge of the company's search for funding options.
Expand
The SP will remain suppressed until they can confirm that they can raise funds without resorting to a CR at a massive discount. The market hates uncertainty especially with their current financial position thanks to PR & the BOD.
(20min delay)